The Bassell Lab published, "Isoform-selective phosphoinositide 3-kinase inhibition ameliorates a broad range of fragile X syndrome-associated deficits in a mouse model", in Neuropsychopharmacology. Christina Gross is first author.
This publication is highlighted in EurekAlert. Click here to link to the highlight.